ADARC CENTER FOR AIDS RESEARCH: VACCINE & THERAPY
ADARC CENTER FOR AIDS RESEARCH: VACCINE & THERAPY
批准号:
6116179
负责人:
DAVID D HO
金额:
$5.31万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2000-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Dr. Torsten Wiesel, President of The Rockefeller University (RU),
and Dr. Herbert Pardes, Dean of the Medical Faculty of Columbia
University (CU), jointly propose the establishment of the
Columbia-Rockefeller Center for AIDS Research (CR-CFAR), an
administrative structure bridging AIDS investigators from our two
Universities located in the City of New York. The CR-CFAR will be
governed by a series of by-laws overseen by Drs. David Ho (Director,
Aaron Diamond AIDS Research Center, RU) and Jeremy Luban (Chief,
Division of Molecular Virology, CU), and by an Executive Steering
Committee consisting of Drs. Yuan Chang, Leonard Chess, Anke Ehrhardt,
Stephen Goff, Wayne Hendrickson, Martin Markowitz, Preston Marx, John
Moore and Ralph Steinman. The CR-CFAR members will be comprised of
over 70 investigators drawn from the Aaron Diamond AIDS Research
Center (RU), the HIV Center for Clinical and Behavioral Studies at the
New York State Psychiatric Institute (CU), the General Clinical
Research Center (GCRC) at the RU Hospital, the Columbia University
Pediatric and Adult ACTUs, seven clinical departments at the
Columbia-Presbyterian Medical Center and at the Harlem Hospital
Medical Center (CU), ten departments of basic science at CU and RU, as
well as the Laboratory for Experimental Medicine and Surgery in
Primates (RU). Two goals unify all CR-CFAR participants. The first
goal is to understand more about the mechanisms of HIV replication,
transmission and pathogenesis, with studies ranging from atomic
resolution of viral protein structure to the psycho-social dynamics of
the inner-city community. The second goal is to integrate this
information into programs developing anti-viral therapeutics and
vaccines, and community outreach and behavioral intervention
strategies. By supporting seven modifiable core facilities
(Administration, Development, Virology, Immunology, Clinical
Resources, Structural Biology and Primate Biology), the CR-CFAR will
promote three major objectives 1) to enhance the outstanding research
programs that are already in place by providing, or simply rendering
more accessible, shared research facilities; 2) to help recruit junior
faculty to our programs and to our institutions, and to encourage
established investigators from within the ranks of our faculty to
develop research programs in AIDS-related topics; and 3) to promote
dialogue leading to new productive collaborations involving CR-CFAR
members. FUNDING PUBLICATIONS None
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiplex Small Molecule Discovery to Identify Broad-Acting Viral Protease Inhibitors
-
批准号:10513925
-
项目类别:
-
资助金额:$354.56万
-
财政年份:2022
-
负责人:DAVID D HO
-
依托单位:
Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.
-
批准号:10078502
-
项目类别:
-
资助金额:$61.45万
-
财政年份:2019
-
负责人:DAVID D HO
-
依托单位:
Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.
-
批准号:10239076
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2019
-
负责人:DAVID D HO
-
依托单位:
Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.
-
批准号:10866743
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2019
-
负责人:DAVID D HO
-
依托单位:
Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.
-
批准号:10005113
-
项目类别:
-
资助金额:$76.2万
-
财政年份:2019
-
负责人:DAVID D HO
-
依托单位:
Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells
-
批准号:10224769
-
项目类别:
-
资助金额:$71.39万
-
财政年份:2017
-
负责人:DAVID D HO
-
依托单位:
Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir
-
批准号:10078006
-
项目类别:
-
资助金额:$20.58万
-
财政年份:2017
-
负责人:DAVID D HO
-
依托单位:
Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells
-
批准号:10083601
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2017
-
负责人:DAVID D HO
-
依托单位:
Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir
-
批准号:10222490
-
项目类别:
-
资助金额:$49.62万
-
财政年份:2017
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8686731
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2012
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8290921
-
项目类别:
-
资助金额:$22.7万
-
财政年份:2012
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8868011
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2012
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8501352
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2012
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8911804
-
项目类别:
-
资助金额:$87.67万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8337121
-
项目类别:
-
资助金额:$74.15万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8716711
-
项目类别:
-
资助金额:$89.0万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8267853
-
项目类别:
-
资助金额:$89.0万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8325003
-
项目类别:
-
资助金额:$89.0万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8522269
-
项目类别:
-
资助金额:$85.44万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
PHASE I STUDY OF CLADE C DNA VACCINE IN HIV
-
批准号:7207025
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2005
-
负责人:DAVID D HO
-
依托单位:
海外基金